Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation

Summary

Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation is a clinical trial^[1].

Key Facts

• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation is in the country of Netherlands^[2].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's instance of is recorded as clinical trial^[3].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's start time is recorded as +2018-08-15T00:00:00Z^[4].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's end time is recorded as +2019-03-30T00:00:00Z^[5].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's sponsor is recorded as VU University Medical Center^[6].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's main subject is recorded as pulmonary valve insufficiency^[7].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's number of participants is recorded as {'unit': '1', 'amount': '+30'}^[8].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's title is recorded as Partial Neuromuscular Blockade to Facilitate Lung and Diaphragm Protective Mechanical Ventilation in Intensive Care Unit Patients: a Randomized Controlled Pilot Study^[9].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's ClinicalTrials.gov ID is recorded as NCT03646266^[11].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's research intervention is recorded as rocuronium^[12].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's research intervention is recorded as bromide^[13].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's clinical trial phase is recorded as phase IV clinical trial^[14].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's research site is recorded as Vrije Universiteit Amsterdam^[15].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's research subject recruitment status is recorded as recruiting^[16].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's research subject recruitment status is recorded as recruiting^[17].
• Partial Neuromuscular Blockade for Lung Protective Mechanical Ventilation's study type is recorded as interventional study^[18].